Rivastigmine in the treatment of Alzheimer's disease: an update

Código QR

Rivastigmine in the treatment of Alzheimer's disease: an update

Maria Luisa Onor, Marianna Trevisiol, Eugenio AgugliaDepartment of Clinical, Morphological and Technological Sciences, U.C.O. of Clinical Psychiatry, University of Trieste, Trieste, ItalyAbstract: Alzheimer’s disease is the most common form of dementia in industrialized countries. In the E...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Maria Luisa Onor, Marianna Trevisiol, Eugenio Aguglia
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2007
Materias:	Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/b446a942660d4761a371fd5f0b56ef12
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis
por: Richard A Hansen, et al.
Publicado: (2008)

Pathogenesis of Alzheimer′s disease
por: Russell H Swerdlow
Publicado: (2007)

Cerebral small vessel disease and Alzheimer’s disease
por: Cai Z, et al.
Publicado: (2015)

Rehabilitating a brain with Alzheimer's: a proposal
por: Gonzalo Emiliano Aranda-Abreu, et al.
Publicado: (2011)

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
por: Sumirtanurdin R, et al.
Publicado: (2019)

Editorial: What's in a name? || Free Paper ||
por: Richard F Walker
Publicado: (2007)

Periodontitis induced by bacterial infection exacerbates features of Alzheimer’s disease in transgenic mice
por: Naoyuki Ishida, et al.
Publicado: (2017)

Abnormal brain cholesterol homeostasis in Alzheimer’s disease—a targeted metabolomic and transcriptomic study
por: Vijay R. Varma, et al.
Publicado: (2021)

Differential transcript usage unravels gene expression alterations in Alzheimer’s disease human brains
por: Diego Marques-Coelho, et al.
Publicado: (2021)

Hearing difficulty is linked to Alzheimer’s disease by common genetic vulnerability, not shared genetic architecture
por: Fatin N. Zainul Abidin, et al.
Publicado: (2021)

Comment: update on the management of constipation in the elderly: new treatment options
por: Lee Techner
Publicado: (2010)

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease
por: Hametner EM, et al.
Publicado: (2012)

Occupational-like organophosphate exposure disrupts microglia and accelerates deficits in a rat model of Alzheimer’s disease
por: Jaymie R. Voorhees, et al.
Publicado: (2019)

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study
por: Yatawara C, et al.
Publicado: (2021)

Update on the use of dutasteride in the management of benign prostatic hypertrophy
por: Joe Miller, et al.
Publicado: (2007)

Update on bazedoxifene: A novel selective estrogen receptor modulator
por: Diane M Biskobing
Publicado: (2007)

HT update: spotlight on estradiol/norethindrone acetate combination therapy
por: Colleen L Casey, et al.
Publicado: (2008)

Electroencephalography-driven approach to prodromal Alzheimer's disease diagnosis: from biomarker integration to network-level comprehension
por: Moretti DV
Publicado: (2016)

Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors
por: Ferris SH, et al.
Publicado: (2013)

Update on the management of constipation in the elderly: new treatment options
por: Satish SC Rao, et al.
Publicado: (2010)

The genetics of Alzheimer's disease
por: Bagyinszky E, et al.
Publicado: (2014)

Classifying late-onset dementia with MRI: Is arteriosclerotic brain degeneration the most common cause of Alzheimer′s syndrome?
por: Marie Cécile Henry-Feugeas, et al.
Publicado: (2008)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Editor's choice: sarcopenia or loss of muscle mass
por: Walker RF
Publicado: (2012)

Treatment of specific phobia in older adults
por: Nancy A Pachana, et al.
Publicado: (2007)

Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence
por: Maria Garefalakis, et al.
Publicado: (2008)

Osteoporosis in the aging male: Treatment options
por: Stephen P Tuck, et al.
Publicado: (2008)

Glucosamine hydrochloride for the treatment of osteoarthritis symptoms
por: Beth Anne Fox, et al.
Publicado: (2008)

Detection of activities of daily living impairment in Alzheimer's disease and mild cognitive impairment using information and communication technology
por: Sacco G, et al.
Publicado: (2012)

Peripheral arterial disease in the elderly
por: Wilbert S Aronow
Publicado: (2008)

Vascular dementia: Pharmacological treatment approaches and perspectives
por: Andrius Baskys, et al.
Publicado: (2007)

Prevention and treatment of venous thromboembolism in the elderly patient
por: Enrico Tincani, et al.
Publicado: (2007)

A review of tazarotene in the treatment of photodamaged skin
por: Stephanie Ogden, et al.
Publicado: (2008)

Pharmacological treatment of neuropathic pain in older persons
por: Clair Haslam, et al.
Publicado: (2008)

Lubiprostone: a novel treatment for chronic constipation
por: Brian E Lacy, et al.
Publicado: (2008)

A review of a bi-layered living cell treatment (Apligraf®) in the treatment of venous leg ulcers and diabetic foot ulcers
por: Larissa Zaulyanov, et al.
Publicado: (2007)

Use of hyaluronic acid fillers for the treatment of the aging face
por: Michael H Gold
Publicado: (2007)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
por: Raja Bobba, et al.
Publicado: (2007)

Female pattern hair loss: Current treatment concepts
por: Quan Q Dinh, et al.
Publicado: (2007)

Intra-articular use of hyaluronic acid in the treatment of osteoarthritis
por: Alberto Migliore, et al.
Publicado: (2008)